HCA Healthcare
Trade HCA Healthcare 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About HCA
HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
HCA Key Statistics
Stock Snapshot
The current HCA Healthcare(HCA) stock price is $471.22, with a market capitalization of 107.53B. The stock trades at a price-to-earnings (P/E) ratio of 18.47 and offers a dividend yield of 60.3%.
During the trading session on 2026-01-07, HCA Healthcare(HCA) shares reached a daily high of $485.00 and a low of $470.88. At a current price of $471.22, the stock is +0.1% higher than the low and still -2.8% under the high.
Trading volume for HCA Healthcare(HCA) stock has reached 464.83K, versus its average volume of 743.89K.
The stock's 52-week range extends from a low of $295.00 to a high of $520.00.
The stock's 52-week range extends from a low of $295.00 to a high of $520.00.
HCA News
Bernstein raised the firm’s price target on HCA Healthcare (HCA) to $503 from $486 and keeps a Market Perform rating on the shares. The firm sees a sector turna...
HCA Healthcare (HCA) is back in focus after fresh Wall Street commentary highlighted margin improvements, firm guidance, and disciplined growth plans, prompting...
Truist lowered the firm’s price target on HCA Healthcare (HCA) to $495 from $520 and keeps a Buy rating on the shares. Truist remains upbeat on the core fundame...
Analyst ratings
54%
of 28 ratingsMore HCA News
HCA Healthcare, Inc.'s ( ) price-to-earnings (or "P/E") ratio of 16.8x might make it look like a buy right now compared to the market in the United States, wher...